{
  "docId": "019de514-f120-743f-9d00-70915b7d1fa5",
  "docSlug": "a9055659e75fd1b92a3c529616eb6953",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 49 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 49,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "propose_solution",
  "function": "propose_solution",
  "density": "overcrowded",
  "nDataPoints": 10,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de514-f120-743f-9d00-70915b7d1fa5/20",
  "deckHref": "/decks/019de514-f120-743f-9d00-70915b7d1fa5",
  "deckJsonHref": "/decks/019de514-f120-743f-9d00-70915b7d1fa5.json",
  "deckAnchorHref": "/decks/019de514-f120-743f-9d00-70915b7d1fa5#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.459,
        "w": 0.502,
        "x": 0.107,
        "y": 0.466
      },
      "kind": "chart",
      "text": "Lumify® Canada Launch Mirroring Success of U.S. Launch (Lumify Dollar Share Evolution in Redness Reliever Category Since Launch)3",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "640a717e-8b58-4f8b-83f4-64501cd26aef",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.58,
        "w": 0.286,
        "x": 0.657,
        "y": 0.301
      },
      "kind": "list",
      "text": "Global expansion with 6 countries, including U.S. and Canada Recently acquired rights for 18 additional countries\nLumify® Eye Illuminations – Expected Launch 1Q23 Specialty eye care line scientifically developed for the sensitive eye area to help enhance eyes' natural beauty\nLumify® Preservative Free (Single Dose) Submission expected 2Q23\nCombination product with ketotifen for allergy symptom control Submission expected in 1Q24",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a36cf7f-daa5-48bc-9537-b8e0bfe7c861",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.26,
        "w": 0.39,
        "x": 0.209,
        "y": 0.175
      },
      "kind": "list",
      "text": "+21% reported revenue growth in FY22 vs. FY21\n+$125M brand4 expanding through geographies and line extensions\n#1 Physician-recommended product in the Redness Reliever category¹\n~50% market share in Redness Reliever Category 2",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6d792b5d-bc73-4287-bfd7-801eee5d0905",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.302,
        "x": 0.16,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. IQVIA ProVoice Survey Data Ending Q3 2022.\n2. IRI Panel Omnichannel. Dollar share.\n3. B+L Consumer Data Science: USA IRI, CAN Nielsen.\n4. Based on trailing twelve-month revenue.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7781bd64-a649-4542-84b2-4a19265a8496",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.889,
        "x": 0.045,
        "y": 0.084
      },
      "kind": "title",
      "text": "LUMIFY®: Strong Established Brand with Expansion Opportunities",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5de93193-8635-4248-91e7-09fc5aee4713",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.286,
        "x": 0.657,
        "y": 0.18
      },
      "kind": "title",
      "text": "Expansion Opportunities for Future Growth in the Lumify® Franchise",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "43da7d98-cff8-4329-bc48-1dc4ee639c53",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 10,
      "beatId": "7dc62337-b2ed-4c41-8d32-808d2f972bf7",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The presentation showcases the company's strong financial performance and strategic advancements, providing satisfaction to investors",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 10,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "d15671c2-99b6-48fa-89dc-6302733eef20",
      "evidence": "The presentation highlights the company's financial performance and strategic advancements, implying the consequences of not investing in Bausch + Lomb",
      "position": 0,
      "objective": "Emphasize the importance of Bausch + Lomb's solutions by highlighting the cost of inaction",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 22,
      "from": 18,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "9ec252cf-371b-49f0-9c44-e9c845dbc6c1",
      "evidence": "The presentation mentions upcoming catalysts and growth opportunities, emphasizing the timeliness of Bausch + Lomb's strategic advancements",
      "position": 1,
      "objective": "Explain why now is the right time for Bausch + Lomb's growth opportunities",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}